Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan

18th December 2018 Uncategorised 0

With its plan for a spinoff into two companies, Mallinckrodt will create an API and generics operation with a large controlled substances and acetaminophen business and seven manufacturing facilities split between the U.S. and Japan.  

More: Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and Japan
Source: fierce